Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society
2020-11-16 20:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
2020-11-16 20:00
KPCPEN Introduces Two Paediatric Professors to Accelerate the Preparation of COVID-19 Vaccine
2020-11-16 16:46
Gilead Sciences Announces Recipients of its First Asia HIV Research Scholar Program
2020-11-16 15:02
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
2020-11-16 14:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
2020-11-16 08:00
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19
2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center
2020-11-14 12:40
International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis
2020-11-14 08:00
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
2020-11-14 05:10
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked
2020-11-14 03:21
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2020-11-14 01:03
FDI World Dental Federation: Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
2020-11-14 01:00
China Jo-Jo Drugstores Reports Second Quarter 2021 Financial Results
2020-11-13 22:00
China Biologic Products to Report Third Quarter 2020 Financial Results
2020-11-13 21:00
The fourth CIIE begins taking stall reservations from exhibitors
2020-11-13 21:00
AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
2020-11-13 20:25
Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer
2020-11-13 17:53
iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay
2020-11-13 16:29
iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay
2020-11-13 15:18
1
601
602
603
604
605
1502